35 related articles for article (PubMed ID: 10372015)
1. Myoepithelial carcinoma of soft tissues and bone.
Aiba H; Errani C; Ciani G; Gambarotti M; Righi A; Maioli M; Spinnato P; Frega G; Ibrahim T; Longhi A
Eur J Cancer; 2023 Nov; 194():113353. PubMed ID: 37852042
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin.
Guthrie TH; McElveen LJ; Porubsky ES; Harmon JD
Cancer; 1985 Apr; 55(8):1629-32. PubMed ID: 4038911
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group.
van Wijk FH; Aapro MS; Bolis G; Chevallier B; van der Burg ME; Poveda A; de Oliveira CF; Tumolo S; Scotto di Palumbo V; Piccart M; Franchi M; Zanaboni F; Lacave AJ; Fontanelli R; Favalli G; Zola P; Guastalla JP; Rosso R; Marth C; Nooij M; Presti M; Scarabelli C; Splinter TA; Ploch E; Beex LV; ten Bokkel Huinink W; Forni M; Melpignano M; Blake P; Kerbrat P; Mendiola C; Cervantes A; Goupil A; Harper PG; Madronal C; Namer M; Scarfone G; Stoot JE; Teodorovic I; Coens C; Vergote I; Vermorken JB;
Ann Oncol; 2003 Mar; 14(3):441-8. PubMed ID: 12598351
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study.
Bramwell VH; Steward WP; Nooij M; Whelan J; Craft AW; Grimer RJ; Taminau AH; Cannon SR; Malcolm AJ; Hogendoorn PC; Uscinska B; Kirkpatrick AL; Machin D; Van Glabbeke MM
J Clin Oncol; 1999 Oct; 17(10):3260-9. PubMed ID: 10506628
[TBL] [Abstract][Full Text] [Related]
5. Thyroid abnormality in patients with psoriasis: prevalence and association with severity.
Fernandes LC; Arruda ACBB; Baeninger LG; Almeida DP; Villagelin D
An Bras Dermatol; 2024; 99(1):80-89. PubMed ID: 37598033
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of non-osteogenic, non-Ewing soft-tissue sarcoma of bone--experience of the Toronto Sarcoma Program.
Veitch ZW; Fasih S; Griffin AM; Al-Ezzi EM; Gupta AA; Ferguson PC; Wunder JS; Abdul Razak AR
Cancer Med; 2020 Dec; 9(24):9282-9292. PubMed ID: 33063945
[TBL] [Abstract][Full Text] [Related]
7. The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma.
Heng M; Gupta A; Chung PW; Healey JH; Vaynrub M; Rose PS; Houdek MT; Lin PP; Bishop AJ; Hornicek FJ; Chen YL; Lozano-Calderon S; Holt GE; Han I; Biau D; Niu X; Bernthal NM; Ferguson PC; Wunder JS; ;
Eur J Cancer; 2020 Jan; 125():130-141. PubMed ID: 31806415
[TBL] [Abstract][Full Text] [Related]
8. DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways.
Maayah ZH; Zhang T; Forrest ML; Alrushaid S; Doschak MR; Davies NM; El-Kadi AOS
Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30181466
[TBL] [Abstract][Full Text] [Related]
9. On the Bayesian Derivation of a Treatment-based Cancer Ontology.
Gao M; Warner J; Yang P; Alterovitz G
AMIA Jt Summits Transl Sci Proc; 2014; 2014():209-17. PubMed ID: 25954588
[TBL] [Abstract][Full Text] [Related]
10. Current strategies of chemotherapy in osteosarcoma.
Carrle D; Bielack SS
Int Orthop; 2006 Dec; 30(6):445-51. PubMed ID: 16896870
[TBL] [Abstract][Full Text] [Related]
11. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma.
Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N
Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472
[TBL] [Abstract][Full Text] [Related]
12. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
[TBL] [Abstract][Full Text] [Related]
13. Primary chemotherapy and delayed surgery for malignant fibrous histiocytoma of bone in the extremity.
Bacci G; Avella M; Picci P; Dallari D; Malaguti C; Biagini R; Ruggieri P; Balladelli A; Ferrari S; Caldora P
Tumori; 1990 Dec; 76(6):537-42. PubMed ID: 2178284
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cell sarcoma: a systematic review.
Howard JE; Dwivedi RC; Masterson L; Jani P
Cancer Treat Rev; 2015 Apr; 41(4):320-31. PubMed ID: 25805533
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-cisplatin chemotherapy for high-grade nonosteogenic sarcoma of bone. Comparison of treatment and control groups.
Waddell AE; Davis AM; Ahn H; Wunder JS; Blackstein ME; Bell RS
Can J Surg; 1999 Jun; 42(3):190-9. PubMed ID: 10372015
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study.
Nooij MA; Whelan J; Bramwell VH; Taminiau AT; Cannon S; Hogendoorn PC; Pringle J; Uscinska BM; Weeden S; Kirkpatrick A; Glabbeke Mv; Craft AW;
Eur J Cancer; 2005 Jan; 41(2):225-30. PubMed ID: 15661546
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
